Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1147-62-2

Post Buying Request

1147-62-2 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

1147-62-2 Usage

Chemical Properties

Off-White to Pale Beige Solid

Uses

A CNS stimulant. Controlled substance (stimulant).

Check Digit Verification of cas no

The CAS Registry Mumber 1147-62-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,4 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1147-62:
(6*1)+(5*1)+(4*4)+(3*7)+(2*6)+(1*2)=62
62 % 10 = 2
So 1147-62-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H23NO.ClH/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14;/h7-10,15H,3-6,11-12H2,1-2H3;1H

1147-62-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Pyrovalerone hydrochloride solution

1.2 Other means of identification

Product number -
Other names 1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1147-62-2 SDS

1147-62-2Upstream product

1147-62-2Downstream Products

1147-62-2Relevant articles and documents

PYROVALERONE ANALOGS AND THERAPEUTIC USES THEREOF

-

Page/Page column 40; 41, (2008/06/13)

New compounds that bind to monoamine transporters are described. The compounds of the present invention can be racemic or pure R-or S-enantiomers. Certain preferred compounds of the present invention have a high selectively dopamine transporter versus the serotonin transporter. Preferred monoamine transporters for the practice of the present invention include the dopamine transporter, the serotonin transporter and the norepinephrine transporter.